This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Hydrochloric acid is a strong acid used to adjust the pH of injections and ophthalmic solutions.
- Generic Name
- Hydrochloric acid
- DrugBank Accession Number
- DB13366
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Hydrochloric acid (DB13366)
- Weight
- Average: 36.461
Monoisotopic: 35.976677739 - Chemical Formula
- ClH
- Synonyms
- Chlorowodor
- Chlorure d'hydrogène
- Chlorwasserstoff
- Cloruro de hidrógeno
- Hydrochloric acid
- Hydrogenchlorid
- Wasserstoffchlorid
- External IDs
- E-507
- INS NO.507
- INS-507
- NSC-77365
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Aminomix 1 Novum - Infusionslösung Hydrochloric acid (1.47 ml/L) + Acetic acid (4.5 g/L) + Alanine (7 g/L) + Arginine (6 g/L) + Calcium chloride (0.294 g/L) + D-glucose monohydrate (220 g/L) + Glycine (5.5 g/L) + Histidine (1.5 g/L) + Isoleucine (2.5 g/L) + Leucine (3.7 g/L) + Lysine hydrochloride (4.125 g/L) + Magnesium chloride hexahydrate (0.61 g/L) + Methionine (2.15 g/L) + Phenylalanine (2.55 g/L) + Potassium hydroxide (1.981 g/L) + Proline (5.6 g/L) + Serine (3.25 g/L) + Sodium chloride (1.169 g/L) + Sodium glycerophosphate (4.59 g/L) + Taurine (0.5 g/L) + Threonine (2.2 g/L) + Tryptophan (1 g/L) + Tyrosine (0.2 g/L) + Valine (3.1 g/L) + Zinc chloride (0.00545 g/L) Solution Intravenous Fresenius Kabi Austria Gmb H 2005-12-05 Not applicable Austria 
Aminomix 2 Novum - Infusionslösung Hydrochloric acid (1.47 ml/L) + Acetic acid (4.5 g/L) + Alanine (7 g/L) + Arginine (6 g/L) + Calcium chloride (0.294 g/L) + Dextrose, unspecified form (120 g/L) + Glycine (5.5 g/L) + Histidine (1.5 g/L) + Isoleucine (2.5 g/L) + Leucine (3.7 g/L) + Lysine hydrochloride (4.125 g/L) + Magnesium chloride hexahydrate (0.61 g/L) + Methionine (2.15 g/L) + Phenylalanine (2.55 g/L) + Potassium hydroxide (1.981 g/L) + Proline (5.6 g/L) + Serine (3.25 g/L) + Sodium chloride (1.169 g/L) + Sodium glycerophosphate (4.59 g/L) + Taurine (0.5 g/L) + Threonine (2.2 g/L) + Tryptophan (1 g/L) + Tyrosine (0.2 g/L) + Valine (3.1 g/L) + Zinc chloride (0.00545 g/L) Solution Intravenous Fresenius Kabi Austria Gmb H 2005-12-05 Not applicable Austria SYVICROM ® 4% SOLUCION OFTALMICA Hydrochloric acid (0 mL) + Benzalkonium chloride (0.1 mg) + Cromoglicate sodium (40 mg) + Edetate disodium anhydrous (1 mg) + Sodium hydroxide (0 mL) + Water (1 mL) Solution Ophthalmic OPHARM LTDA. 2019-05-21 Not applicable Colombia 
Categories
- ATC Codes
- B05XA13 — Hydrochloric acid
- B05XA — Electrolyte solutions
- B05X — I.V. SOLUTION ADDITIVES
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
- B — BLOOD AND BLOOD FORMING ORGANS
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as halogen hydrides. These are inorganic compounds in which the heaviest atom bonded to a hydrogen atom is a halogen.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous non-metal compounds
- Class
- Halogen organides
- Sub Class
- Halogen hydrides
- Direct Parent
- Halogen hydrides
- Alternative Parents
- Inorganic hydrides
- Substituents
- Halogen hydride / Inorganic hydride
- Molecular Framework
- Not Available
- External Descriptors
- hydrogen halide, mononuclear parent hydride, chlorine molecular entity (CHEBI:17883) / a small molecule (HCL)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- QTT17582CB
- CAS number
- 7647-01-0
- InChI Key
- VEXZGXHMUGYJMC-UHFFFAOYSA-N
- InChI
- InChI=1S/ClH/h1H
- IUPAC Name
- hydrogen chloride
- SMILES
- Cl
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0002306
- KEGG Drug
- D02057
- KEGG Compound
- C01327
- ChemSpider
- 307
- 5486
- ChEBI
- 17883
- ChEMBL
- CHEMBL1231821
- Wikipedia
- Hydrochloric_acid
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Thyroid Eye Disease 1 2 Recruiting Treatment Efficacy of Ensatinib in This Subset of Patients / Second Generation ALK-TKI is Resistant / The Diagnosis Was ALK Positive NSCLC 1 Not Available Recruiting Treatment Central Line Associated Blood Stream Infections (CLABSI) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intravenous Solution Intravenous Solution Ophthalmic - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0 mg/mL ALOGPS logP -1.3 ALOGPS logP 0.61 Chemaxon logS 1.08 ALOGPS pKa (Strongest Acidic) -7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 6.42 m3·mol-1 Chemaxon Polarizability 2.65 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available MS/MS Spectrum - Linear Ion Trap , negative LC-MS/MS splash10-0a4i-0000009000-8651ed5a563be0ad942f MS/MS Spectrum - Linear Ion Trap , negative LC-MS/MS splash10-0a4i-0000009000-6193af2f15253417208c MS/MS Spectrum - Linear Ion Trap , positive LC-MS/MS splash10-014i-0000900000-5818c00db6f91eb3e74d
Drug created at June 23, 2017 20:40 / Updated at June 02, 2021 20:04